Bizarre Patents
Mouthguard made at least partially from an edible candy
A mouthguard includes a U-shaped upper bite plate which removably fits over upper teeth of a person, with the entire upper bite plate being made from a soft, deformable and edible gummi candy.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7271269 | Preparation of new pharmaceutically suitable salt of losartan and forms thereof with new purification and isolation methods Pharmaceutically suitable crystalline and amorphous alkali and earth-alkali salts of 2-n-butyl-4-chloro-5-hidrox-ymethyl-1-[[2′-(1 H-tetrazole-5-yl)[1.1′-biphenyl]-4-yl]-1 Himidazole have been prepared and new manufacturing, purification and isolation procedure ... | 09/18/2007 |
| 7235248 | Pharmaceutical compositions comprising cyclosporins Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva]2-Ciclosporin, in “microemulsion pre-concentrate” and microemulsion form. The compositions typically comprise (1.1) a C1-5alkyl or tetrahydrofurfuryl di- or part... | 06/26/2007 |
| 7153970 | High purity amlodipine benzenesulfonate and a process for its preparation 3-ethyl 5-methyl (+/−) 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate benzenesulfonate, containing overall impurities of significantly less than 0.3% is disclosed, as well as process for its preparation, according to wh... | 12/26/2006 |
| 7098362 | Processes for the preparation of gabapentin The present invention relates to new processes for the preparation of gabapentin by the desilylation of a silylated gabapentin or by the silylation-desilylation of an acid addition salt of gabapentin with a silylating agent. ... | 08/29/2006 |
| H2158 | Process for the production of clavulanic acid salts Use of the 2-amino-2,4,4-trimethylpentane salt of clavulanic acid as an intermediate in the production of pharmaceutically acceptable salts of clavulanic acid. ... | 06/06/2006 |
| 7030151 | Atorvastatin calcium in a pharmaceutical form composition thereof and pharmaceutical formulation comprising atorvastatin calcium Atorvastatin calcium, the substance known by the chemical name (R—(R*,R*))-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid hemi calcium salt is known as HMG-CoA reductase inhibitor and is used as a... | 04/18/2006 |
| 6962924 | Salt and polymorphs of desloratadine hemifumarate This invention provides a process of preparation of novel polymorphic hemifumarate salts of 8-chloro-6,11-dihyfro-11-(4-piperidylidene)-5H-benzo[5,6]-cyclohepta[1,2-b]pyridine, hereinafter called “desloratadine”. These polymorphic salt forms show much higher sol... | 11/08/2005 |
| 6949641 | Crystalline β-lactam intermediate The novel intermediate compound crystalline 7-[2-(2-fomylaminothiazol-4-yl)-2 -(Z)-(methoxyimino)acetamido]-3-methoxymethyl-3-cephem-4-carboxylic acid-1 -(isopropoxy/crystallization of cefpodoxime proxetil. The crystallization process comprises dissolving or suspend... | 09/27/2005 |
| 6949519 | Macrolide solvates Azithromycin in the form of a monohydrate comprising from 4.0% to 6.5% of water, a process for its preparation and its use in pharmaceutical compositions. ... | 09/27/2005 |
| 6936455 | Production of heterologous proteins using an Npro autoprotease of a pestivirus and inclusion bodies The present invention relates to a process for the recombinant production of a desired heterologous polypeptide with a clearly defined homogenous N-terminus in a bacteria host cell. A fusion comprising a peptide with the autoproteolytic activity of an autoprotease N... | 08/30/2005 |
| 6933410 | Process for preparing 5,6-diethyl-2,3-dihydro-1H-inden-2-amine A process for preparing 5,6-diethyl-2,3-dihydro-1H-inden-2-amine and acid addition salts thereof from 2-aminoindan. The process comprises protecting the amino group of 2-aminoindan, acetylating the ring in the protected compound, reducing the acetyl group to ethyl t... | 08/23/2005 |
| 6911472 | Pharmaceutical composition comprising a hmg-coa reductase inhibitor A pharmaceutical composition comprising as an active ingredient an HMG-CoA reductase inhibitor and an aminosugar. ... | 06/28/2005 |
| 6897307 | Process for preparing 2,6-diaminopurine derivatives A one-pot process for preparing 2,6-diaminopurine derivatives or an acid addition salt thereof comprising: (i) reacting a purine compound with an amine compound in the presence of a tertiary amine at a pH of 7 to 14 to form a 6-substituted aminopurine derivative, an... | 05/24/2005 |
| 6878749 | Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes The invention relates to a combination, such as a combined preparation or pharmaceutical composition, respectively, which comprises nateglinide (1) stet or repaglinide and at least one other antidiabetic compound selec... | 04/12/2005 |
| 6869963 | Stable pharmaceutical compositions containing an ACE inhibitor A stable pharmaceutical composition comprising about 1 wt. % to about 80 wt. % of an ACE inhibitor or a pharmaceutical acceptable salt thereof, about 1 wt. % to about 70 wt. % of an alkali or alkaline earth metal carbonate, and about 1 wt. % to about 80 wt. % of hyd... | 03/22/2005 |
| 6835838 | Process for the manufacture of organic compounds A method for preparing an alkali metal salt comprising: (a) condensing a disilyloxydiene with an aldehyde in the presence of a titanium (IV) catalyst in an inert solvent to form a 5(S)-hydroxy-3-ketoester; (b) reducing the 5(S)-hydroxy-3-ketoester to a 3(R),5(S)-dih... | 12/28/2004 |
| 6835829 | Purification process Processes for the depletion of 7-ADCA in mixtures of vinyl-ACA with 7-ADCA via novel salts of vinyl-ACA or via chromatography. ... | 12/28/2004 |
| 6825345 | Process for purification of a cephalosporin derivative A process for the purification of cefixime via a novel tert-octylamine salt of a cefixime intermediate of formula V which may be crystalline and which may be produced in a one-pot reaction from 7-amino-3-vinyl-ceph-3-e... | 11/30/2004 |
| 6787649 | Cephalosporin intermediates A process which comprises (i) acylating a compound of formula II with a compound of formula IV to obtain a compound of formula I ... | 09/07/2004 |
| 6784193 | Mutilin derivatives and their use as antibacterials A compound of formula (I) wherein R2 is arylene or heterocyclene; or R and R2 together with the nitrogen atom to which they are attached form non-aromatic heterocyclene; and the other residues have various meanings, useful as pharmaceuticals, e... | 08/31/2004 |
| 6777549 | β-lactam production A process for the production of a compound of formula comprising i) silylating a compound of formula then reacting a resulting with a compound of formula | 08/17/2004 |
| 6767555 | Pharmaceutical compositions This invention provides composition comprising a cyclosporin and a carrier medium. ... | 07/27/2004 |
| 6753445 | Pleuromutilin derivatives having antibacterial activity A compound selected from 14—O—[(cycloalkyl-sulfanyl)acetyl]mutilins; 14—O—[(cycloalkyl-alkyl-sulfanyl)acetyl] mutilins; 14—O—[(cycloalkoxy)acetyl] mutilins; and 14—O—[(cycloalkyl-alkoxy)acetyl] mutilins and its use as a pharmaceutical. ... | 06/22/2004 |
| 6740776 | Air oxidation of an aromatic aldehyde to an aromatic acid A low temperature process for preparing an aromatic acid having formula (I), said process comprising reacting an aromatic aldehyde having formula (II) with a gas having an ox... | 05/25/2004 |
| 6723339 | Oil-free pharmaceutical compositions containing cyclosporin A The present invention provides a hard gelatine capsule containing a pharmaceutical composition comprising cyclosporin A in a mixture with a surfactant of HLB value at least 10, substantially free of any oil and when a hydrophilic phase is present, the hydrophilic ph... | 04/20/2004 |
| 6670477 | Synthesis of enantiomerically enriched 4-piperidinylglycine A process for making enantiomerically enriched 4-piperidinylglycine having the formula (I), ##STR1## said process comprising (a) combining N-protected glycine ester with 4-piperidone to form didehydroamino acid ester; (b) reducing the didehydroamino ... | 12/30/2003 |
| 6653503 | Microwave irradiation process for preparing methyl esters An accelerated process for preparing a methyl ester having formula (III) ##STR1## said process comprising reacting a carboxylic acid or salt thereof having formula (I) ##STR2## with dimethyl carbonate having formula (II) ##STR3## in the presence of a... | 11/25/2003 |
| 6649168 | Pharmaceutical compositions comprising TGF-beta This invention provides pharmaceutical compositions comprising TGF-ଲ.... | 11/18/2003 |
| 6605613 | Macrolides A mixture comprising a poly-ene macrolide and an antioxidant. Preferably, the poly-ene macrolide is rapamycin and the antioxidant is 2,6-di-tert.-butyl-4-methylphenol. The presence of the antioxidant improves the stability of the poly-ene macrolide to oxi... | 08/12/2003 |
| 6599535 | Pharmaceutical compositions A pharmaceutical composition in the form of a solid dispersion comprising a macrolide, e.g. a rapamycin or an ascomycin, and a carrier medium.... | 07/29/2003 |
| 6596877 | Accelerated process for preparing O-methyl phenols, N-methyl heteroaromatic compounds, and methylated aminophenols An accelerated process for preparing an O-methyl phenol comprising reacting a phenol with dimethyl carbonate in the presence of a catalyst selected from 1,8-diazabicyclo[5.4.0]undec-7-ene; 1,4-diazabicyclo[2.2.2]octane; and dimethylaminopyridine. Accordin... | 07/22/2003 |
| 6596260 | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol The invention relates to an aerosol container for pharmaceutically active aerosols that are to be administered in predetermined amounts and that are supplied in the container in the form of a suspension, the suspension also comprising, in addition to a ph... | 07/22/2003 |
| 6589536 | Soft gelatin capsule manufacture Soft gelatin capsules having a capsule shell comprising gelatin, plasticizers and, if desired or required, further auxiliary agents, and a capsule filling containing a solvent including a migrateable solvent such as 1,2-propyleneglycol as a solvent in the... | 07/08/2003 |
| 6559188 | Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes The invention relates to a combination, such as a combined preparation or pharmaceutical composition, respectively, which comprises nateglinide (I) ##STR1## or repaglinide and at least one other antidiabetic compound selected from the group consisting of ... | 05/06/2003 |
| 6555132 | Soft gelatin capsule manufacture Soft gelatin capsules having a capsule shell comprising gelatin, plasticizers and, if desired or required, further auxiliary agents, and a capsule filling containing a solvent including a migrateable solvent such as 1,2-propyleneglycol as a solvent in the... | 04/29/2003 |
| 6515167 | Low temperature process for preparing methyl esters A low temperature process for preparing a methyl ester having formula (III) ##STR1## said process comprising reacting a carboxylic acid or salt thereof having formula (I) ##STR2## with dimethyl carbonate having formula (II) ##STR3## in the presence o... | 02/04/2003 |
| 6503883 | Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis The invention relates to a pharmaceutical preparation, which contains an immunosuppressive active agent in dissolved form in a starch capsule, or hard or soft gelatin capsule which has been coated with one or several polymer films. The invention further r... | 01/07/2003 |
| 6475519 | Oil-free pharmaceutical compositions containing cyclosporin A The present invention provides a hard gelatine capsule containing a pharmaceutical composition comprising cyclosporin A in a mixture with a surfactant of HLB value of at least 10, substantially free of any oil and when a hydrophilic phase is present, the ... | 11/05/2002 |
| 6468968 | Cyclosporin galenic forms Pharmaceutical compositions comprising a cyclosporin as active ingredient, a fatty acid triglyceride, a glycerol fatty acid partial ester or propylene glycol or sorbitol complete or partial ester, preferably, and a tenside having an HLB of at least 10.... | 10/22/2002 |
| 6458770 | Parenteral formulations comprising carbamazepine or its derivatives The invention is concerned with a parenteral formulation comprising a 5H-dibenz(b,f)azepine-5-carboxamide and an aqueous-based solvent. The parenteral formulation is useful in the treatment of seizures resulting from, e.g. epileptic attack.... | 10/01/2002 |
